Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
BMC Rheumatology|July 2, 2021
Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potentialMichael J Grayling, Theophile Bigirumurame, Svetlana Cherlin, et al.
Statistics in Medicine|January 13, 2022
Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trialsKevin Kunzmann, Michael J Grayling, Kim May Lee, et al.
Clinical Trials (London, England)|December 21, 2019
Designing and evaluating dose-escalation studies made easy: The MoDEsT web appPhilip Pallmann, Fang Wan, Adrian P Mander, et al.
The American Statistician|January 7, 2022
A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory TrialsKevin Kunzmann, Michael J Grayling, Kim May Lee, et al.
The British Journal of Nutrition|September 26, 2013
Age and sex differences in the incorporation of EPA and DHA into plasma fractions, cells and adipose tissue in humansCelia G Walker, Lucy M Browning, Adrian P Mander, et al.
British Journal of Cancer|November 9, 2021
Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trialsHelen Mossop, Michael J Grayling, Ferdia A Gallagher, et al.
BMC Public Health|January 25, 2011
Dietary energy density and adiposity: employing bias adjustments in a meta-analysis of prospective studiesDésirée C Wilks, Adrian P Mander, Susan A Jebb, et al.
The Journal of Nutrition|October 29, 2010
How much human milk do infants consume? Data from 12 countries using a standardized stable isotope methodologyTeresa H M da Costa, Hinke Haisma, Jonathan C K Wells, et al.
Pageof 14